The Irbesartan Type II Diabetic Nephropathy Trial: study design and baseline patient characteristics. - Rodby,RA.; Rohde,RD.; Clarke,WR.; Hunsicker,LG.; Anzalone,DA.; Atkins,RC.; Ritz,E.; Lewis,EJ. (Nephrol Dial Transplant, 2000)